InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.690 0.005 (0.72%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$188 Trading Halt 2 Dec 2016 7:28PM $0.455 $0.690 risen by 51.65%
$188 Change of Director's Interest Notice PA 2 Dec 2016 5:30PM $0.455 $0.690 risen by 51.65%
$188 Investor Presentation 2 Dec 2016 9:22AM $0.430 $0.690 risen by 60.47%
$188 Appendix 3B 28 Nov 2016 8:23PM $0.450 $0.690 risen by 53.33%
$188 Results of Meeting 28 Nov 2016 4:43PM $0.450 $0.690 risen by 53.33%
$188 Appendix 4C - quarterly 31 Oct 2016 6:43PM $0.450 $0.690 risen by 53.33%
$188 WA Innovation Excellence Award for CelGro Received 31 Oct 2016 2:01PM $0.445 $0.690 risen by 55.06%
$188 Orthocell Announces Growth Factor - Cell factory Publication 31 Oct 2016 9:36AM $0.435 $0.690 risen by 58.62%
$188 Appendix 4G 26 Oct 2016 8:03PM $0.420 $0.690 risen by 64.29%
$188 Annual Report to shareholders 26 Oct 2016 8:02PM $0.420 $0.690 risen by 64.29%
$188 Notice of Annual General Meeting/Proxy Form 26 Oct 2016 8:00PM $0.420 $0.690 risen by 64.29%
$188 Approval for CelGro Human Nerve Regeneration Study Received 18 Oct 2016 9:32AM $0.420 $0.690 risen by 64.29%
$188 Appendix 3B 14 Oct 2016 8:26AM $0.435 $0.690 risen by 58.62%
$188 Investor Presentation CelGro 19 Sep 2016 8:58AM $0.385 $0.690 risen by 79.22%
$188 Research Report 14 Sep 2016 11:59AM $0.385 $0.690 risen by 79.22%
$188 Full Year Statutory Accounts 12 Sep 2016 7:27PM $0.345 $0.690 risen by 100%
$188 Amended Change of Director's Interest Notice MC 12 Sep 2016 7:23PM $0.345 $0.690 risen by 100%
$188 Preliminary Final Report 31 Aug 2016 5:29PM $0.350 $0.690 risen by 97.14%
$188 Release of Securities from Escrow 2 Aug 2016 6:39PM $0.370 $0.690 risen by 86.49%
$188 Appendix 4C - quarterly 29 Jul 2016 1:18PM $0.380 $0.690 risen by 81.58%
$188 Ethics Approval for Pivotal Ortho ATI Tendon Study Received 12 Jul 2016 9:23AM $0.315 $0.690 risen by 119.05%
$188 Change of Director's Interest Notice SW 1 Jul 2016 7:13PM $0.300 $0.690 risen by 130%
$188 United States Tendon Stem Cell and Scaffold Patent Obtained 21 Jun 2016 9:21AM $0.335 $0.690 risen by 105.97%
$188 Chinese Patent Received Covering Celgro SMART Graft 17 Jun 2016 10:16AM $0.340 $0.690 risen by 102.94%
$188 Early Positive Results for CelGro in Human Tendon Study 16 Jun 2016 8:55AM $0.315 $0.690 risen by 119.05%

676 - 700 of 771 results

Page 28 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.